Who / What
Henrietta Lacks (née Loretta Pleasant) was an African American woman whose cells became the source of the HeLa cell line. This cell line is significant as the first immortalized human cell line, providing invaluable data for medical research.
Background & History
Henrietta Lacks was born in 1920 and died in 1951. Her cancer cells were taken from a tumor biopsied during her treatment for cervical cancer at Johns Hopkins Hospital in Baltimore, Maryland, in 1951. Unbeknownst to her, these cells were isolated and began to replicate, forming the HeLa cell line. This development occurred during a time when informed consent for medical research was not fully established.
Why Notable
Henrietta Lacks is notable because her cells are the foundation of the HeLa cell line, which has been instrumental in countless medical breakthroughs and research advancements. The HeLa cell line continues to be used today for studying diseases, developing vaccines, and testing drug efficacy. Her story highlights ethical considerations in medical research and the importance of informed consent.
In the News
The HeLa cell line remains highly relevant in modern medical research, with ongoing applications in cancer research, virology, and genetic studies. Ethical debates surrounding the use of HeLa cells continue, focusing on Henrietta Lacks' legacy and the rights of individuals whose biological material is used for research.
